Mode
Text Size
Log in / Sign up
N/A N=39 Randomized Treatment

A Physical Activity Program to Disrupt Sedentary Time in Older Latinos

Sedentary Behavior · Cognitive Impairment

Enrolled (actual)
39
Serious AEs
0.0%
Results posted
Jul 2023
Primary outcome: Primary: Number of Sedentary Bouts — -11.58; -2.47 Sedentary bouts

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Ecological Momentary Intervention (Behavioral)
Age
Adult, Older Adult · 55+ yrs
Sex
All
Sponsor
University of Illinois at Chicago
Primary completion
Apr 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Sedentary Bouts
-11.58; -2.47
PRIMARY
Time in Sedentary Bouts
-347.7; -27.53
SECONDARY
Trail Making Test A
.43; .31
SECONDARY
Trail Making Test B
-35.26; 7.19
SECONDARY
Picture Vocabulary Test
.20; .25
SECONDARY
List Sorting
1.26; 5.53
SECONDARY
Picture Sequence
4.26; 4.32
SECONDARY
Oral Reading Recognition Test
6.89; 1
SECONDARY
Crystalized Cognition
3.95; .95
SECONDARY
Auditory Verbal Learning
.26; .47
SECONDARY
Text Message Motivation.
8.7
SECONDARY
Enjoyment of the Text Messages.
8.8
SECONDARY
Text Messages Helping Exercise.
8.9
SECONDARY
Difficulty Understanding Text Messages
0.9
SECONDARY
Enjoyment of the Program.
9.4
SECONDARY
Difficulty With the FitBit.
1.7

Summary

To test the feasibility of an intervention designed to replace sedentary time with physical activity in older Latinos, delivered in their homes to improve cognitive function and brain connectivity.

Eligibility Criteria

Inclusion Criteria

  • no history of major head trauma
  • ownership of a smartphone
  • ability to make video calls

Exclusion Criteria

  • Requires assistive ambulation;
  • Unstable angina,
  • Claudication
  • severe arthritis,
  • extreme dyspnea on exertion,
  • Class III-IV heart failure;
  • Current uncontrolled sustained arrhythmias,
  • severe/symptomatic aortic or mitral stenosis,
  • hypertrophic obstructive cardiomyopathy,
  • severe pulmonary hypertension,
  • active myocarditis/pericarditis,
  • thrombophlebitis,
  • recent systemic/pulmonary embolus (within 3 months);
  • Revascularization procedures within the previous 6 months;
  • Pregnancy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04507464). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search